|
TOR1AIP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59737999999576E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06459999985142E-07 |
| Normal-vs-Stage2 |
3.276000E-02 |
| Normal-vs-Stage3 |
8.356400E-02 |
| Normal-vs-Stage4 |
4.257800E-01 |
| Stage1-vs-Stage2 |
3.034600E-01 |
| Stage1-vs-Stage3 |
2.748200E-01 |
| Stage1-vs-Stage4 |
4.499800E-01 |
| Stage2-vs-Stage3 |
8.697800E-01 |
| Stage2-vs-Stage4 |
7.549400E-01 |
| Stage3-vs-Stage4 |
8.655000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.80573999999378E-05 |
| Normal-vs-AfricanAmerican |
6.01510000000083E-05 |
| Normal-vs-Asian |
8.46850000000288E-05 |
| Caucasian-vs-AfricanAmerican |
7.158200E-01 |
| Caucasian-vs-Asian |
2.220000E-01 |
| AfricanAmerican-vs-Asian |
2.017800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.46649999979809E-07 |
| Normal-vs-Female |
1.321970E-01 |
| Male-vs-Female |
3.718300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.296500E-03 |
| Normal-vs-Extreme_Weight |
3.15260000327555E-08 |
| Normal-vs-Obese |
3.103700E-03 |
| Normal-vs-Extreme_Obese |
8.443800E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.020400E-02 |
| Normal_Weight-vs-Obese |
6.777200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.069400E-01 |
| Extreme_Weight-vs-Obese |
4.164800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.472400E-01 |
| Obese-vs-Extreme_Obese |
2.804200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.573200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.968700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.12039999999869E-06 |
| Normal-vs-Age(81-100Yrs) |
5.59860000026724E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.623600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.910570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.977800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.406240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.321700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.505900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.1654999998445E-07 |
| Normal-VS-Type2 PRCC |
1.679900E-03 |
| Normal-VS-KIRP CIMP |
7.646200E-01 |
| Normal-VS-Unclassified PRCC |
1.799960E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.175600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.448000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.461900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.930400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.978200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.125800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.1544000000363E-07 |
| Normal-vs-N1 |
8.341000E-01 |
| Normal-vs-N2 |
8.503000E-01 |
| N0-vs-N1 |
2.279700E-02 |
| N0-vs-N2 |
4.232000E-01 |
| N1-vs-N2 |
9.164600E-01 |
|
|
